Last reviewed · How we verify
Tranexamic Acid 1 gram intravenously
At a glance
| Generic name | Tranexamic Acid 1 gram intravenously |
|---|---|
| Sponsor | London School of Hygiene and Tropical Medicine |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Tranexamic Acid for The Treatment of Gastrointestinal Bleeding (NA)
- Tranexamic Acid vs Vasopressin in Placenta Previa Trial (PHASE3)
- A Trial of a Hospital Policy of Tranexamic Acid Use to Reduce Transfusion in Major Non-cardiac Surgery (PHASE4)
- Indian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage (PHASE4)
- Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial) (PHASE3)
- Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion (PHASE4)
- Comparison of the Efficacy of Misoprostol and Tranexamic Acid for Postpartum Hemorrhage Prophylaxis in Cesarean Delivery
- Tranexamic Acid to Reduce Blood Loss in Women Having Planned Cesarean Section (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: